Lianhe Sowell International Group Ltd Receives Nasdaq Minimum Bid Price Deficiency Notice
SHENZHEN, China, Jan. 27, 2026 /PRNewswire/ -- Lianhe Sowell International Group Ltd (Nasdaq: LHSW) today announced that it has received a notice (the "Notice") from The Nasdaq Stock Market LLC ("Nasdaq") dated January 22, 2026 stating that the...
Revenera Receives Frost & Sullivan's 2026 Global Product Leadership Recognition for Excellence in Software Value Chain Enablement
The company is recognized for its market-leading software monetization innovation, end-to-end life cycle enablement, and customer-centric product leadership. SAN ANTONIO, Jan. 27, 2026 /PRNewswire/ -- Frost & Sullivan is pleased to announce that...
Innovent Announces IBI3003 (GPRC5D/BCMA/CD3 Trispecific Antibody) Receives Fast Track Designation from the U.S. FDA for Relapsed or Refractory Multiple Myeloma
SAN FRANCISCO and SUZHOU, China, Jan. 27, 2026 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, and commercializes high-quality medicines for the treatment of...
Frost & Sullivan: Mercanis Receives the 2025 European Agentic AI Product Leadership Recognition for its Excellence in Intelligent Procurement Transformation
Frost & Sullivan recognizes Mercanis for product innovation, customer-centricity, and AI leadership in redefining digital procurement across Europe. SAN ANTONIO, Jan. 26, 2026 /PRNewswire/ -- Frost & Sullivan is pleased to announce that...
Accevo Receives Frost & Sullivan's 2025 European Enabling Technology Leadership Recognition for Manufacturing Software in Smart Factories
The company is acknowledged for enabling digital transformation, performance-driven smart manufacturing, and scalable manufacturing software innovation across European factories and globally. SAN ANTONIO, Jan. 26, 2026 /PRNewswire/ -- Frost &...
CNEY Receives Nasdaq Delisting Determination for Minimum Bid Price Deficiency
LISHUI, China, Jan. 24, 2026 /PRNewswire/ -- CN Energy Group. Inc. (NASDAQ: CNEY) ("CNEY" or the "Company"), a Nasdaq-listed company, today announced that it received a written notice from the Listing Qualifications Staff of The Nasdaq Stock Market...
Insilico Medicine Receives IND Approval from FDA for ISM8969, an AI-empowered Potential Best-in-class NLRP3 Inhibitor
Investigational New Drug (IND) approval from the U.S. Food and Drug Administration (FDA) paves the way for ISM8969 clinical study in the United States. The Phase I clinical trial aims to evaluate safety, tolerability, and pharmacokinetics profiles....
D3 Bio Receives U.S. FDA Clearance for Two IND Applications, Enabling Phase 1 Trial of D3S‑003 and Phase 2 Combination Study of Elisrasib (D3S‑001) with D3S‑002
SHANGHAI, Jan. 19, 2026 /PRNewswire/ -- D3 Bio, a global clinical‑stage biotechnology company focused on developing transformative oncology therapeutics, today announced that the U.S. Food and Drug Administration (FDA) has cleared two...
WuXi AppTec Receives Double "A" Rating from CDP for Climate Change and Water Security Leadership
SHANGHAI, Jan. 19, 2026 /PRNewswire/ -- WuXi AppTec, a leading global pharmaceutical CRDMO (Contract Research, Development, and Manufacturing Organization), today announced that it has been recognized on the "A List" for leadership in corporate...
Aeronero Receives Frost & Sullivan's 2025 Global Transformational Innovation Leadership Recognition for Pioneering Advancements in Atmospheric Water Generation
Recognized for redefining water security through breakthrough hybrid atmospheric water generation technology and sustainable innovation SAN ANTONIO, Jan. 13, 2026 /PRNewswire/ -- Frost & Sullivan is pleased to announce that Aeronero has been...